[Over the weekend Gilead presented results from its combination of sofosbuvir and daclatasvir that cured between 98 and 100 percent of patients within 12 weeks.]
Are they assuming that DACLATASVIR belongs to GILEAD? Did Gilead buy Bristol-Myers too?
The trial for 7977+BMS790052(=Daclatasvir) had 3 arms, and all 3 arms dosed the dual or triple (the 3rd was Riba) combos that lasted 24 weeks, not 12weeks! Where do they get the news?
Gilead is now developing 7977+5885, and decided not to develop 7977+Daclatasvir combo.